The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer - PubMed (original) (raw)
Practice Guideline
The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer
Herbert Chen et al. Pancreas. 2010 Aug.
Abstract
Pheochromocytomas, intra-adrenal paraganglioma, and extra-adrenal sympathetic and parasympathetic paragangliomas are neuroendocrine tumors derived from adrenal chromaffin cells or similar cells in extra-adrenal sympathetic and parasympathetic paraganglia, respectively. Serious morbidity and mortality rates associated with these tumors are related to the potent effects of catecholamines on various organs, especially those of the cardiovascular system. Before any surgical procedure is done, preoperative blockade is necessary to protect the patient against significant release of catecholamines due to anesthesia and surgical manipulation of the tumor. Treatment options vary with the extent of the disease, with laparoscopic surgery being the preferred treatment for removal of primary tumors. Medullary thyroid cancer (MTC) is a malignancy of the thyroid C cells or parafollicular cells. Thyroid C cells elaborate a number of peptides and hormones, such as calcitonin, carcinoembryonic antigen, and chromogranin A. Some or all of these markers are elevated in patients with MTC and can be used to confirm the diagnosis as well as to follow patients longitudinally for recurrence. Medullary thyroid cancer consists of a spectrum of diseases that ranges from extremely indolent tumors that are stable for many years to aggressive types associated with a high mortality rate. Genetic testing for RET mutations has allowed identification of familial cases and prophylactic thyroidectomy for cure. The only curative treatment is complete surgical resection.
Similar articles
- Pheochromocytomas and Paragangliomas.
Tevosian SG, Ghayee HK. Tevosian SG, et al. Endocrinol Metab Clin North Am. 2019 Dec;48(4):727-750. doi: 10.1016/j.ecl.2019.08.006. Endocrinol Metab Clin North Am. 2019. PMID: 31655773 Review. - Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
Moraitis AG, Martucci VL, Pacak K. Moraitis AG, et al. Endocr Pract. 2014 Feb;20(2):176-87. doi: 10.4158/EP13268.RA. Endocr Pract. 2014. PMID: 24449662 Review. - The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, Dahia PLM, Fraker DL, Goodman KA, Hope TA, Kunz PL, Perez K, Perrier ND, Pryma DA, Ryder M, Sasson AR, Soulen MC, Jimenez C. Fishbein L, et al. Pancreas. 2021 Apr 1;50(4):469-493. doi: 10.1097/MPA.0000000000001792. Pancreas. 2021. PMID: 33939658 - [Diagnosis and management of patients with pheochromocytoma/paraganglioma: Consensus of experts of the Russian Medical Society for Arterial Hypertension and the Multidisciplinary Group for the Diagnosis and Treatment of Neuroendocrine Tumors].
Blinova NV, Ilovayskaya IA, Chikhladze NM, Lugovskaya AY, Britvin TA, Gurevich LE, Nefedova LN, Shikina VE, Chazova IE. Blinova NV, et al. Ter Arkh. 2024 Jul 30;96(7):645-658. doi: 10.26442/00403660.2024.07.202779. Ter Arkh. 2024. PMID: 39106507 Russian. - Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
Maia AL, Siqueira DR, Kulcsar MA, Tincani AJ, Mazeto GM, Maciel LM. Maia AL, et al. Arq Bras Endocrinol Metabol. 2014 Oct;58(7):667-700. doi: 10.1590/0004-2730000003427. Arq Bras Endocrinol Metabol. 2014. PMID: 25372577 English, Portuguese.
Cited by
- A Rare Case of Paraganglioma Syndrome Associated With Polycythemia and Blindness.
Esaki Y, Liao X, Harbuz-Miller I. Esaki Y, et al. Cureus. 2024 Jun 24;16(6):e63047. doi: 10.7759/cureus.63047. eCollection 2024 Jun. Cureus. 2024. PMID: 39050329 Free PMC article. - A rare case of retroperitoneal paraganglioma located in the neck of the pancreas: a case report and literature review.
Wang W, Qin Y, Zhang H, Chen K, Liu Z, Zheng S. Wang W, et al. Gland Surg. 2021 Apr;10(4):1523-1531. doi: 10.21037/gs-20-758. Gland Surg. 2021. PMID: 33968704 Free PMC article. - Functional Malignant Retroperitoneal Paraganglioma with Liver Metastasis: a Rare Case Report.
Kadam SS, Hegde S, Galage A, Kadam T. Kadam SS, et al. Indian J Surg Oncol. 2021 Apr;12(Suppl 1):186-192. doi: 10.1007/s13193-020-01259-4. Epub 2021 Jan 5. Indian J Surg Oncol. 2021. PMID: 33994745 Free PMC article. - Laparoscopic adrenalectomy for pheochromocytoma-does size matter? A single surgeon comparative study.
Rao N, Ramachandran R, Tandon N, Singh P, Kumar R. Rao N, et al. Transl Androl Urol. 2016 Oct;5(5):780-783. doi: 10.21037/tau.2016.08.10. Transl Androl Urol. 2016. PMID: 27785436 Free PMC article. - An Extra-adrenal Pheochromocytoma Presenting as Malignant Hypertension-A Report of two cases.
Kumar U M, Pande P, Savita S, Pk A, Yelikar BR. Kumar U M, et al. J Clin Diagn Res. 2013 Jun;7(6):1177-9. doi: 10.7860/JCDR/2013/5139.3046. Epub 2013 Jun 1. J Clin Diagn Res. 2013. PMID: 23905134 Free PMC article.
References
- Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665–675. - PubMed
- DeLellis RA, Lloyd RV, Heitz PU, Eng C. Tumours of Endocrine Organs. Lyon: IARC Press; 2004.
- Elder EE, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. J Surg Oncol. 2005;89(3):193–201. - PubMed
- Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med. 2002;346(19):1459–1466. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials